http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104688672-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
filingDate | 2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104688672-B |
titleOfInvention | Puerarin gel eyedrop is preparing the application in treating retinopathy medicine |
abstract | A kind of Puerarin gel eyedrop is preparing the application in treating retinopathy medicine, the eye drops is made up of Puerarin, EDTA, sodium pyrosulfite, borneol, benzalkonium bromide, pool Lip river yarn nurse 407, Sodium Hyaluronate, sodium citrate, citric acid and water for injection, with HPLC UV methods, proved through pharmacokinetics in rabbit eyes:Uptake of the 1.2% Puerarin gel eyedrop in retina, choroid is respectively greater than the 70% and 62% of Puerarin ordinary eye drops;By aqueous humor, the conversion of vitreum proportion, intraocular puerarin content choroid>Retina>Aqueous humor>Vitreum, disclose Puerarin and absorbed on eyeground and can reach enough contents into eyeground.It is observed that 1.2% Puerarin gel eyedrop measures the medicine average content on curve each time point in 16 hours Puerarins on rabbit retina, choroid(ng/g)Rabbit when not less than retinal haemodynamics measure effectively causes the content measured during the VPV enhancing of eyeground(ng/g);So as to confirm that Puerarin gel eyedrop can be used as intravenous puerarin for treating retinopathy. |
priorityDate | 2014-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.